SCYL1 and post-transplant lymphoproliferative disease: Among these 5 EBV-LPDs, EBV+ T-LPD cases accounted for the largest proportion (100 cases, 65.36%) followed by ENKTL-NT, CSEBV+ T-LPD, PTLD, and NKTL.